arrow
T

Taís Nóbrega de Sousa

karoinska institutet
H指数:23
被引数:1,569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa

撒哈拉以南非洲广泛存在的恶性疟原虫疫苗候选抗原MSP2的多态性变异体

2026-07-220
OAAI
Hidden Infections, Emerging Resistance: Underdiagnosed Plasmodium vivax and multidrug resistance-1 (pvmdr1) gene Amplification in the Guiana Shield

隐性感染,新兴耐药:圭亚那地盾地区被诊断不足的Plasmodium vivax及多药耐药-1 (pvmdr1)基因扩增

2026-06-150
OAAI
Naturally acquired antibodies to Plasmodium vivax Pv_LISP-2; a potential liver stage vaccine antigen

自然获得的抗恶性疟原虫Pv_LISP-2抗体;一种潜在肝脏阶段疫苗抗原

2026-03-270
OA
How Duffy Blood Group (FY) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon

Duffy Blood Group (FY)基因多态性和年龄如何影响社区层面间日疟的风险:亚马逊地区的一项基于人群的回顾性队列研究

2025-11-010
OAAI
How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil

CYP2D6多态性如何调节社区范围的间日疟原虫感染风险:一项在巴西亚马逊地区进行的队列研究

2025-09-010
OA
Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa

非洲地区与Plasmodium falciparum plasmepsin 3拷贝数变异相关的二氢青蒿素-哌喹对复发性疟疾保护作用的降低

2025-03-180
OA
Exploring the naturally acquired response to Pvs47 gametocyte antigen
2024-10-100
OAAI